Login / Signup

Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.

Hermine I BrunnerNikolay TzaribachevIngrid LouwInmaculada Calvo PenadesFrancisco Avila-ZapataGerd HorneffIvan FoeldvariDaniel J KingsburyMaria Eliana Paz GastanagaCarine WoutersJohannes BreedtRobert WongMargarita AskelsonJoe ZhuoAlberto MartiniDaniel J LovellNicolino Rupertonull null
Published in: Arthritis care & research (2023)
Among individual patients with pJIA treated with abatacept who achieved one of the combined clinical and PRO composite endpoints, many maintained them over 21 months of abatacept treatment.
Keyphrases
  • juvenile idiopathic arthritis
  • rheumatoid arthritis
  • disease activity
  • rheumatoid arthritis patients
  • systemic lupus erythematosus
  • anti inflammatory